-
-
-
-
-
-
-
NRX Pharmaceuticals begins commercial manufacturing for preservative-free ketamine
-
-
-
-
-
-
-
New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)
-
-
-
-
-
-
-
NRx Pharmaceuticals names Joshua Brown as chief medical innovation officer
-
-
-
-
-
-
-
NRx Pharmaceuticals receives FDA review for preservative-free ketamine
-
-
-
-
-
-
-
NRx Pharmaceuticals re-files drug application for preservative-free ketamine
-
-
-
-
-
-
-
NRx Pharmaceuticals, Inc. (NRXP) PT Raised to $34 at D. Boral Capital
-
-
-
-
-
-
-
New to The Street Show #680 to Air Saturday, July 26 at 6:30 PM EST on Bloomberg TV
-
416,809 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

